BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7837933)

  • 1. Mode of action of bullatacin, a potent antitumor acetogenin: inhibition of NADH oxidase activity of HeLa and HL-60, but not liver, plasma membranes.
    Morré DJ; de Cabo R; Farley C; Oberlies NH; McLaughlin JL
    Life Sci; 1995; 56(5):343-8. PubMed ID: 7837933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mode of action of the anticancer quassinoids--inhibition of the plasma membrane NADH oxidase.
    Morré DJ; Grieco PA; Morré DM
    Life Sci; 1998; 63(7):595-604. PubMed ID: 9718085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984) inhibits NADH oxidase activity of HeLa plasma membranes.
    Morré DJ; Wu LY; Morré DM
    Biochim Biophys Acta; 1995 Nov; 1240(1):11-7. PubMed ID: 7495842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the drug-responsive NADH oxidase of the cancer cell plasma membrane a molecular target for adriamycin?
    Morré DJ; Kim C; Paulik M; Morré DM; Faulk WP
    J Bioenerg Biomembr; 1997 Jun; 29(3):269-80. PubMed ID: 9298712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of action of bullatacin: a potent antitumor and pesticidal annonaceous acetogenin.
    Ahammadsahib KI; Hollingworth RM; McGovren JP; Hui YH; McLaughlin JL
    Life Sci; 1993; 53(14):1113-20. PubMed ID: 8371627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A growth factor- and hormone-stimulated NADH oxidase from rat liver plasma membrane.
    Brightman AO; Wang J; Miu RK; Sun IL; Barr R; Crane FL; Morré DJ
    Biochim Biophys Acta; 1992 Mar; 1105(1):109-17. PubMed ID: 1567890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NADH oxidase activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984) at an external site.
    Morré DJ
    Biochim Biophys Acta; 1995 Dec; 1240(2):201-8. PubMed ID: 8541291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bullatacin, a potent antitumor annonaceous acetogenin, inhibits proliferation of human hepatocarcinoma cell line 2.2.15 by apoptosis induction.
    Chih HW; Chiu HF; Tang KS; Chang FR; Wu YC
    Life Sci; 2001 Aug; 69(11):1321-31. PubMed ID: 11521756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of a cell-surface NADH oxidase to the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenylurea) (LY181984) modulated by redox.
    Morré DJ; Wu LY; Morré DM
    Biochim Biophys Acta; 1998 Mar; 1369(2):185-92. PubMed ID: 9518604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential response of the NADH oxidase of plasma membranes of rat liver and hepatoma and HeLa cells to thiol reagents.
    Morré DJ; Morré DM
    J Bioenerg Biomembr; 1995 Feb; 27(1):137-44. PubMed ID: 7629045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capsaicin inhibits plasma membrane NADH oxidase and growth of human and mouse melanoma lines.
    Morré DJ; Sun E; Geilen C; Wu LY; de Cabo R; Krasagakis K; Orfanos CE; Morré DM
    Eur J Cancer; 1996 Oct; 32A(11):1995-2003. PubMed ID: 8943687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New cytotoxic benzo(b)thiophenilsulfonamide 1,1-dioxide derivatives inhibit a NADH oxidase located in plasma membranes of tumour cells.
    Alonso MM; Encío I; Martínez-Merino V; Gil M; Migliaccio M
    Br J Cancer; 2001 Nov; 85(9):1400-2. PubMed ID: 11720481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture.
    Morré DJ; Chueh PJ; Morré DM
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):1831-5. PubMed ID: 7892186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of transplasma membrane electron transport by transferrin-adriamycin conjugates.
    Sun IL; Sun EE; Crane FL; Morré DJ; Faulk WP
    Biochim Biophys Acta; 1992 Mar; 1105(1):84-8. PubMed ID: 1567898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor sulfonylurea-inhibited NADH oxidase of cultured HeLa cells shed into media.
    Morré DJ; Wilkinson FE; Kim C; Cho N; Lawrence J; Morré DM; McClure D
    Biochim Biophys Acta; 1996 Apr; 1280(2):197-206. PubMed ID: 8639694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic AMP-plus ATP-dependent modulation of the NADH oxidase activity of porcine liver plasma membranes.
    Morré DJ; Navas P; Rodriguez-Aguilera JC; Morré DM; Villalba JM; de Cabo R; Lawrence J
    Biochim Biophys Acta; 1994 Dec; 1224(3):566-74. PubMed ID: 7803517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The plasma membrane NADH oxidase of HeLa cells has hydroquinone oxidase activity.
    Kishi T; Morré DM; Morré DJ
    Biochim Biophys Acta; 1999 May; 1412(1):66-77. PubMed ID: 10354495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal relationship between cytosolic NADH and ENOX2 inhibition triggers sphingolipid-induced apoptosis in HeLa cells.
    De Luca T; Morré DM; Morré DJ
    J Cell Biochem; 2010 Aug; 110(6):1504-11. PubMed ID: 20518072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of plasma membrane NADH oxidase activity and growth of HeLa cells by natural and synthetic retinoids.
    Dai S; Morré DJ; Geilen CC; Almond-Roesler B; Orfanos CE; Morré DM
    Mol Cell Biochem; 1997 Jan; 166(1-2):101-9. PubMed ID: 9046026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sulfonylurea-inhibited NADH oxidase activity of HeLa cell plasma membranes has properties of a protein disulfide-thiol oxidoreductase with protein disulfide-thiol interchange activity.
    Morré DJ; Chueh PJ; Lawler J; Morré DM
    J Bioenerg Biomembr; 1998 Oct; 30(5):477-87. PubMed ID: 9932650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.